{"id":71,"date":"2021-11-23T14:51:36","date_gmt":"2021-11-23T07:51:36","guid":{"rendered":"https:\/\/conf.icgbio.ru\/biomed2016\/?page_id=71"},"modified":"2021-11-23T15:34:02","modified_gmt":"2021-11-23T08:34:02","slug":"program","status":"publish","type":"page","link":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/program\/","title":{"rendered":"Preliminary program"},"content":{"rendered":"<p><\/p>\n<h2><b>Schedule of the forum \u00abBiomedicine-2016\u00bb<\/b><\/h2>\n<p><b>June 26<\/b><br \/>\narrival day<\/p>\n<p><b>June 27<\/b><br \/>\nplenary lections<br \/>\nround-table \u00abOn the threshold of new biomedicine \u2013 perspectives of adopting the draft law on turnover of biomedical cell products\u00bb<br \/>\ndemonstration of the film \u00abSic transit gloria mundi\u00bb devoted to \u0410.\u0410. Maximov<\/p>\n<p><b>June 28-30<\/b><br \/>\nround-table discussions<br \/>\nposter session<\/p>\n<p><b>July 1<\/b><br \/>\ndeparture day<\/p>\n<h2><b>Plenary lections<\/b><\/h2>\n<ul>\n<li>Agladze K. \u00abWhy does modern medicine need tissue engineering\u00bb<\/li>\n<li>Vlassov V. \u00abCell technologies in medicine of the future\u00bb<\/li>\n<li>Zharkov D. \u00abEditing epigenome: if it is possible and necessary\u00bb<\/li>\n<li>Deev S. \u00abTheranostics in modern biomedicine\u00bb<\/li>\n<li>Illarioshkin S. \u00abNewest molecular and cellular technologies in studying neurodegenerative diseases\u00bb<\/li>\n<li>Lavrik O. &#8220;DNA reparation systems as platforms to create drugs and increase efficiency of gene therapy&#8221;<\/li>\n<li>Leonov S. \u00abIs it possible to achieve neuroregeneration under neurodegenerative conditions\u00bb<\/li>\n<li>Makarevich P. \u00abGene therapy in regenerative medicine: results and further perspectives\u00bb<\/li>\n<li>Medvedev S. \u00abCRISPR-revolution in biology and medicine\u00bb<\/li>\n<li>Parfyonova E. \u00abPerspectives of myocardium regeneration\u00bb<\/li>\n<li>Rubtsov N. \u00abProblem of genetic diversity and genetic instability in studies using human stem cells\u00bb<\/li>\n<li>Taranin A. \u00abImmunotherapy: new molecular and cellular tools in cancer treatment\u00bb<\/li>\n<li>Tomilin A. \u00abLatest achievements of new technologies based on pluripotent stem cells\u00bb<\/li>\n<li>Vasiliev A. &#8220;Achievements and perspectives of cell technologies&#8221;<\/li>\n<\/ul>\n<p><\/p>","protected":false},"excerpt":{"rendered":"<p>Schedule of the forum \u00abBiomedicine-2016\u00bb June 26 arrival day June 27 plenary lections round-table \u00abOn the threshold of new biomedicine \u2013 perspectives of adopting the draft law on turnover of biomedical cell products\u00bb demonstration of the film \u00abSic transit gloria &hellip; <a href=\"https:\/\/conf.icgbio.ru\/biomed2016\/en\/program\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":13,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/pages\/71"}],"collection":[{"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/comments?post=71"}],"version-history":[{"count":3,"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/pages\/71\/revisions"}],"predecessor-version":[{"id":114,"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/pages\/71\/revisions\/114"}],"wp:attachment":[{"href":"https:\/\/conf.icgbio.ru\/biomed2016\/en\/wp-json\/wp\/v2\/media?parent=71"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}